Dr. Tarun Singhal, MD

Dr. Singhal practices at Sturdy Memorial Hospital in Attleboro, Massachusetts, part of Sturdy Health.

Dr. Singhal's NPI, 1205000148, was assigned on April 22, 2008. Dr. Singhal holds Massachusetts license FS4671841.

Dr. Singhal's primary practice is Sturdy Memorial Hospital, at 211 Park Street, Attleboro, MA 02703 in Bristol County. The practice phone is (508) 222-5200.

Dr. Singhal's primary practice is Sturdy Memorial Hospital in Attleboro, Massachusetts, part of Sturdy Health. Dr. Singhal is also affiliated with Brigham and Women's Hospital. The medical group on file is Sturdy Memorial Hospital. Dmand AI also links Dr. Singhal to 1 more breast imaging center, 1 imaging center and 1 medical group, each named with a free account. Dr. Singhal's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singhal practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Singhal's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Singhal is licensed in Massachusetts.

CMS data shows 148 Medicare services from Dr. Singhal across 3 procedure codes in 2024, for 58 Medicare patients. Medicare paid $11,047 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 58 Medicare patients who saw Dr. Singhal in 2024. The largest group is under 65, with 39 patients. 60% of them have high cholesterol, and 55% have high blood pressure. 60% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Singhal's median patient age at 63, with 75% women.

In 2024, Dr. Singhal wrote 1,374 Medicare Part D claims for 89 patients. 78% of them were for generic drugs. CMS names the drug for 1,103 of them, across 30 drugs with 11 or more claims each, at $1,583,343 in total drug cost. In 2023, CMS named 1,171 claims across 31 drugs.

Dr. Singhal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 34 papers to Dr. Singhal, published from 2012 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Positron-Emission Tomography, Multiple Sclerosis and Magnetic Resonance Imaging. Dr. Singhal has published most often in Clin Nucl Med. Dr. Singhal's most frequent co-authors are Steven Michael Cicero, DO, Howard Lee Weiner, MD and Jonathan Douglas Zurawski.

Dmand AI links Dr. Singhal to 1 clinical trial.

CMS Open Payments shows 220 general payments to Dr. Singhal from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Eisai Inc. paid the most, $10,987. It also lists 1 research payment totaling $7,228 in 2025.